<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00979186</url>
  </required_header>
  <id_info>
    <org_study_id>CI-08-0005</org_study_id>
    <nct_id>NCT00979186</nct_id>
  </id_info>
  <brief_title>A Trial to Evaluate Natural Orifice Transgastric Endoscopic Cholecystectomy With Laparoscopic Assistance</brief_title>
  <official_title>A Trial to Evaluate Natural Orifice Transgastric Endoscopic Cholecystectomy With Laparoscopic Assistance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ethicon Endo-Surgery</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ethicon Endo-Surgery</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will document being able to successfully perform transgastric cholecystectomy&#xD;
      (laparoscopic visualization) using a small collection of study surgical tools.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Study Terminated - No enrollment, business decision.&#xD;
  </why_stopped>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Proportion of procedures completed</measure>
    <time_frame>1 Day</time_frame>
    <description>Day of surgery only - study complete at end of prodecure.</description>
  </primary_outcome>
  <enrollment type="Actual">0</enrollment>
  <condition>Cholecystectomy</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NOTES GEN 1 Toolbox</intervention_name>
    <description>Articulating Hook Knife, Articulating Snare, Articulating Needle Knife Articulating Graspers, Articulating Biopsy Forceps, Steerable Flex Trocar with Rotary Access Needle, Flexible Bipolar Hemostasis Forceps, Flexible Maryland Dissector, and Tissue Apposition System.</description>
    <other_name>Articulating Hook Knife, Articulating Snare, Articulating Needle Knife</other_name>
    <other_name>Articulating Graspers, Articulating Biopsy Forceps, Steerable Flex Trocar with Rotary Access Needle,</other_name>
    <other_name>Flexible Bipolar Hemostasis Forceps, Flexible Maryland Dissector, and Tissue Apposition System.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Men and women will be enrolled in this study who:&#xD;
&#xD;
          -  Are willing to give consent and comply with evaluation and treatment schedule, able to&#xD;
             understand and complete study questionnaires;&#xD;
&#xD;
          -  At least 18 years of age;&#xD;
&#xD;
          -  Have a clinical diagnosis of gallbladder disease indicated for cholecystectomy;&#xD;
&#xD;
          -  ASA Classification I or II (Appendix II); and&#xD;
&#xD;
          -  Have a negative serum pregnancy test (for women of childbearing potential);&#xD;
&#xD;
          -  Have the study procedure attempted.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  BMI &gt; 35;&#xD;
&#xD;
          -  Use of immunosuppressive medications (within 6 months of surgery; single burst dosages&#xD;
             and inhalable steroids are acceptable);&#xD;
&#xD;
          -  Suspicion of gallbladder cancer, tumor, polyps, or mass;&#xD;
&#xD;
          -  Acute cholecystitis or acute pancreatitis;&#xD;
&#xD;
          -  Presence of common bile duct stones;&#xD;
&#xD;
          -  History of open abdominal surgery;&#xD;
&#xD;
          -  Evidence of abdominal abscess or mass;&#xD;
&#xD;
          -  Diffuse peritonitis;&#xD;
&#xD;
          -  Use of anticoagulants or anti-platelet agents (use of daily cardio protective doses of&#xD;
             aspirin, up to 81 mg/day, is acceptable and shall not constitute an exclusion&#xD;
             criterion) or the presence of coagulopathy;&#xD;
&#xD;
          -  Clinical diagnosis of sepsis;&#xD;
&#xD;
          -  History of peritoneal trauma;&#xD;
&#xD;
          -  Co-morbid condition(s) that could limit the subject's ability to participate in the&#xD;
             study or to comply with follow-up requirements, or that could impact the scientific&#xD;
             integrity of the trial;&#xD;
&#xD;
          -  Planned concurrent surgical procedure;&#xD;
&#xD;
          -  Prior or planned major surgical procedure within 30 days before or after study&#xD;
             procedure;&#xD;
&#xD;
          -  Previous diagnosis of intra-abdominal adhesions;&#xD;
&#xD;
          -  Participation in any other investigational device or drug trial that has not completed&#xD;
             the primary endpoint or that clinically interferes with the current study endpoints;&#xD;
&#xD;
          -  Previously enrolled in the current series of 4 trials investigating the EES NOTES GEN1&#xD;
             Toolbox; or&#xD;
&#xD;
          -  Any condition which precludes compliance with the study (Investigator discretion).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Surgery, UCSD</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2010</verification_date>
  <study_first_submitted>September 16, 2009</study_first_submitted>
  <study_first_submitted_qc>September 16, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 17, 2009</study_first_posted>
  <last_update_submitted>November 28, 2011</last_update_submitted>
  <last_update_submitted_qc>November 28, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 29, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>transgastric cholecystectomy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemostatics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

